Allergic Rhinitis in Remission after House Dust Mite Subcutaneous Immunotherapy

Supamas Harintajinda,Potjanee Kiewngam,Wanlapa Jotikasthira,Adithep Sawatchai,Natchanun Klangkalya,Watcharoot Kanchongkittiphon,Wiparat Manuyakorn

Journal of Allergy and Clinical Immunology（2023）

引用 0|浏览1

暂无评分

摘要

Subcutaneous immunotherapy (SCIT) is a treatment option for patients with allergic rhinitis (AR) whose symptoms persist after optimal usage of medications. The objective of this study is to identify factors that predict AR in remission after completing the house dust mite (HDM) SCIT.

查看译文

关键词

allergic rhinitis,subcutaneous immunotherapy,house dust

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要